Medical Breakthroughs from Penn Medicine ReachMD

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Elise Chong, MD



Patients with follicular lymphoma who relapse or don’t respond to treatment don’t have many therapeutic options, but a recently FDA-approved CAR T-cell therapy may help change that. Dr. Charles Turck is joined by Dr. Elise Chong from Penn Medicine’s Abramson Cancer Center to explore this new treatment option.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Kirstin Leitner, MD



Current screening tools for postpartum depression may have limitations, but a new texting service as part of the Healing at Home program may help clinicians detect postpartum depression earlier. Dr. Charles Turck is joined by Dr. Kirstin Leitner to take a look at this program and its impacts.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Kathryn Gallagher, MS, RN, BSN

Guest: Kate Newcomb-DeSanto, MSN, RN, MSW



What does Penn Medicine’s newly-opened patient room facility have to offer? Dr. Charles Turck is joined by Penn Medicine Clinical Advisors Kathy Gallagher and Kate Newcomb-DeSanto to discuss the new pavilion and how it's revolutionizing patient care.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Drew Weissman, MD, PhD



Dr. Drew Weissman, Professor of Medicine at Penn Medicine joins Dr. Turck to discuss his new COVID-19 vaccine technology and how RNA and mRNA are being used to provoke an immune response in order to combat the COVID-19 pandemic.

Host: Jennifer Caudle, DO

Guest: Kathleen E. O'Neill, MD, MTR

Guest: Nawar Abdul Latif, MD, MPH, MSCE



Patients with uterine factor infertility, or UFI, only had two options if they wanted to achieve parenthood: using a gestational carrier or adoption. Until now.
Joining Dr. Jennifer Caudle to talk about the opportunities of uterine transplants and key information about the UNTIL trial are lead investigators Drs. Kathleen O’Neill and Nawar Latif from Penn Medicine.

Host: Jennifer Caudle, DO

Guest: Amit Bar-Or, MD, FRCP, FAAN, FANA



Joining Dr. Jennifer Caudle to discuss the latest research furthering our understanding and treatment of multiple sclerosis is Dr. Amit Bar-Or, Chief of the Multiple Sclerosis Division and Director for the Center of Neuroinflammation and Neurotherapeutics at Penn Medicine. Could these recent findings finally help us solve some of the unanswered questions of multiple sclerosis?